Mad in America

JULY 13, 2024

But Ghaemi wants to claim that lithium is special—that it does more than target symptom mechanisms, it modifies the disease process that underpins bipolar disorder. “ Methods that ignore information from double-zero studies or use continuity corrections should no longer be used ” ( Kuss, 2015).

Bipolar disorder 145

Bipolar disorder Pharmaceuticals 145

Mad in America

OCTOBER 30, 2023

The textbook authors might have referred to his 2015 Cochrane review, which found that every single trial ever performed of stimulants in children with an ADHD diagnosis was at high risk of bias. Nothing in Insel’s narrative would harm psychiatry’s guild interests or pharmaceutical interests. This is mendacious.

Pharmaceuticals 133

Pharmaceuticals Manufacturing Bipolar disorder Self-awareness 133

Mad in America

JANUARY 4, 2025

Pigott and colleagues published articles in 2015 and 2018 on the STAR*D trial, and each time Mad in America reviewed the articles. At that time, the American Psychiatric Association (APA) launched a public relations campaign to sell this new model to the public (an effort that was funded in large part by pharmaceutical companies).

Pharmaceuticals 145

Pharmaceuticals Neurotransmitters and mental health Sleep and mental health Aging and mental health 145

Mad in America

JANUARY 14, 2025

They are the German judge Daniel Paul Schreber (1842-1911), the German philosopher Friedrich Nietzsche (1844-1900), the Qubec poet mile Nelligan (1879-1941) and the American mathematician John Nash (1928-2015). I have published articles about all four of them in the Journal of Literature and Art Studies. They are available online.

Trauma and the brain 104

Trauma and the brain Hospitality Pharmaceuticals Bipolar disorder 104

Mad in America

NOVEMBER 6, 2023

As Whitaker noted, the research literature shows that psychosis pills and depression pills increase the chronicity of the disorders, and the same is true for stimulants, benzodiazepines, and drugs used for bipolar disorder. 650 None of this history is found in Insel’s book or on NIMH’s website.

Bipolar disorder 145

Bipolar disorder Neurotransmitters and mental health Genetics and mental health Pharmaceuticals 145

Mad in America

OCTOBER 21, 2023

Thomas Insel, director of the National Institute of Mental Health (NIMH) from 2002-2015, acknowledged in 2011, “Whatever we’ve been doing for five de­cades, it ain’t working. The psychiatric-pharmaceutical-industrial complex is fueled by the profits of Big Pharma, which have made a staggering amount of money from psychiatric drugs.

Technology 144

Technology Genetics and mental health Pharmaceuticals Sleep and mental health 144